Literature DB >> 21686805

Capecitabine (oral 5-fluorouracil pro-drug) treatment for colorectal carcinoma causing ischaemic chest pain.

Trevor Aidan McGoldrick1, Duncan Jodrell, Sally Clive.   

Abstract

We present a case of cardiac ischaemia associated with capecitabine chemotherapy. An elderly female receiving capecitabine chemotherapy developed acute onset severe anterior chest pain associated with ischaemic changes on ECG. The pain and ECG changes failed to respond to thrombolysis and she proceeded to coronary angiogram and stenting of a thrombosed right coronary vessel. She inadvertently recommenced her capecitabine with a further episode of chest pain. On cessation of capecitabine she had no further episodes of chest pain.

Entities:  

Year:  2009        PMID: 21686805      PMCID: PMC3028446          DOI: 10.1136/bcr.07.2008.0449

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation.

Authors:  S Kinhult; M Albertsson; J Eskilsson; M Cwikiel
Journal:  Scanning       Date:  2001 Jan-Feb       Impact factor: 1.932

Review 2.  The cardiotoxicity of chemotherapeutic drugs.

Authors:  A Allen
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

3.  Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.

Authors:  Søren Astrup Jensen; Jens Benn Sørensen
Journal:  Cancer Chemother Pharmacol       Date:  2006-01-18       Impact factor: 3.333

4.  [Cardiovascular disorders in the course of antimitotic infusions at high doses. 30 clinical cases].

Authors:  T Gaveau; P Banzet; H Marneffe; P Viars
Journal:  Anesth Analg (Paris)       Date:  1969 May-Jun

5.  Letter: 5-Fluorouracil and angina.

Authors:  R G Dent; I McColl
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

Review 6.  Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.

Authors:  Myriam Malet-Martino; Véronique Gilard; Franck Desmoulin; Robert Martino
Journal:  Clin Chim Acta       Date:  2005-12-06       Impact factor: 3.786

Review 7.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

8.  The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).

Authors:  Matthew Ng; David Cunningham; Andrew R Norman
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

9.  Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.

Authors:  Rita M Cool; Jon D Herrington; Lucas Wong
Journal:  Pharmacotherapy       Date:  2002-09       Impact factor: 4.705

10.  Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.

Authors:  M de Forni; M C Malet-Martino; P Jaillais; R E Shubinski; J M Bachaud; L Lemaire; P Canal; C Chevreau; D Carrié; P Soulié
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.